In this single-blind , randomised , multicentre , non-inferiority trial ( Shockless IMPLant Evaluation [ SIMPLE ] ) , we recruited patients aged older than 18 years receiving their first ICD for standard indications at 85 hospitals in 18 countries worldwide .